We would like to thank Dr Bishu 1 for his interest in our study that investigated the effect of pulmonary hypertension (PH) hemodynamic presentation on 1-year clinical outcomes after transcatheter aortic valve implantation (TAVI). 2 We observed that patients with isolated postcapillary PH had clinical outcomes similar to patients without PH, whereas combined postcapillary and precapillary PH was a strong predictor of all-cause mortality at 1 year after adjustment for several comorbidities. 2 We agree with Dr Bishu 1 that raw pulmonary artery systolic pressure (PASP) estimates alone provide prognostic information among patients with severe aortic stenosis undergoing both TAVI and surgical aortic valve replacement as has been shown in several studies.3-6 However, raw PASP estimates provide no information whatsoever about the likely cause of PH. Conversely, by stratifying patients according to hemodynamic presentation, it is possible to differentiate PH because of left heart disease (ie, postcapillary PH or group 2 PH) from other PH subgroups (ie, precapillary PH-groups 1, 3, 4, and 5 PH).2 It is intuitive that PH severity would only improve after TAVI among patients with PH because of left heart disease but would not improve among patients with PH unrelated to left heart disease. Our study was the first to demonstrate this to be the case. 2 We observed that both PASP and right ventricular function improved after TAVI among patients with group 2 PH only. Conversely, neither PASP nor right ventricular function improved among patients with other forms of PH (collectively known as precapillary PH). 2 We also demonstrated that PASP can improve among patients with combined PH, thereby highlighting the fact that this PH subgroup is not always irreversible despite the putative hypertrophic changes in the medial layer of the pulmonary arterioles in such patients. Therefore, the new PH classification provides not only prognostic information but also, in addition, provides an indication as to which patients may or may not have a significant reduction in PASP after TAVI. This is important because persistently elevated PASP after TAVI has recently been shown to be a poor prognostic indicator. 5 The new PH classification may help identify such patients before TAVI, thereby helping to improve overall risk stratification and patient selection. The question of whether raw PASP estimates or hemodynamic groupings of PH provide more prognostic information is largely irrelevant. Patients with combined PH will invariably have higher PASPs when compared with other subgroups because the definition requires an elevated diastolic pressure gradient ≥7 mm Hg (ie, diastolic pulmonary artery pressure minus mean pulmonary artery wedge pressure or left ventricular end-diastolic pressure). Both variables provide complementary information, but the PH hemodynamic classification also provides information about the likely response to treatment in addition to being a prognostic indicator. Indeed, the new updated PH classification may be useful to help...